- Q1 2024 AtriCure Inc Earnings Call TranscriptMay 01, 2024$24.76 (+2.65%)Earnings
- Q4 2023 AtriCure Inc Earnings Call TranscriptFeb 15, 2024$34.21 (+5.13%)Earnings
- AtriCure Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 AtriCure Inc Earnings Call TranscriptNov 01, 2023$35.01 (+1.07%)Earnings
- Q2 2023 AtriCure Inc Earnings Call TranscriptJul 25, 2023$53.19 (-0.28%)Earnings
- AtriCure Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 AtriCure Inc Earnings Call TranscriptMay 02, 2023$43.94 (-2.62%)Earnings
- AtriCure Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 AtriCure Inc Earnings Call TranscriptFeb 21, 2023$39.24 (-2.73%)Earnings
- AtriCure Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 AtriCure Inc Earnings Call TranscriptNov 01, 2022$42.94 (+1.95%)Earnings
- AtriCure Inc To Host an Investor Education Webcast TranscriptSep 28, 2022
- AtriCure Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 AtriCure Inc Earnings Call TranscriptAug 02, 2022$49.69 (+1.72%)Earnings
- Q1 2022 AtriCure Inc Earnings Call TranscriptMay 03, 2022$54.63 (-0.22%)Earnings
- Q4 2021 AtriCure Inc Earnings Call TranscriptFeb 15, 2022$65.5 (+2.02%)Earnings
- AtriCure Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 AtriCure Inc Earnings Call TranscriptNov 03, 2021$78.42 (+1.00%)Earnings
- AtriCure Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 AtriCure Inc Earnings Call TranscriptAug 04, 2021$81.88 (-1.96%)Earnings
- AtriCure Inc Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 AtriCure Inc Earnings Call TranscriptApr 27, 2021$64.91 (-1.65%)Earnings
- Q4 2020 AtriCure Inc Earnings Call TranscriptFeb 23, 2021$62.24 (-4.55%)Earnings
- AtriCure Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 AtriCure Inc Earnings Call TranscriptNov 05, 2020$37.12 (+1.28%)Earnings
- AtriCure Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 AtriCure Inc Earnings Call TranscriptJul 28, 2020$44.67 (-2.21%)Earnings
- AtriCure Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- AtriCure Inc CONVERGE Trial Results -- Investor and Analyst Discussion TranscriptMay 08, 2020
- Q1 2020 AtriCure Inc Earnings Call TranscriptApr 29, 2020$41.39 (+5.61%)Earnings
- Q4 2019 AtriCure Inc Earnings Call TranscriptFeb 18, 2020$43.16 (-1.55%)Earnings
- AtriCure Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 AtriCure Inc Earnings Call TranscriptOct 30, 2019$27.15 (-0.80%)Earnings
- AtriCure Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- AtriCure Inc to Acquire SentreHEART - M&A Call TranscriptAug 12, 2019
- Q2 2019 AtriCure Inc Earnings Call TranscriptJul 30, 2019$32.2 (+1.67%)Earnings
- Q1 2019 AtriCure Inc Earnings Call TranscriptApr 25, 2019$28.17 (+0.75%)Earnings
- AtriCure Inc at Needham Healthcare Conference TranscriptApr 10, 2019
- Q4 2018 AtriCure Inc Earnings Call TranscriptFeb 28, 2019$31.94 (-2.05%)Earnings
AtriCure Inc CONVERGE Trial Results -- Investor and Analyst Discussion Transcript
Good afternoon and welcome to AtriCure's Investor and Analyst Meeting in conjunction with HRS. My name is Stacy, and I will be your coordinator for the call today. (Operator Instructions) We will be facilitating a question-and-answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Lynn Lewis from Gilmartin Group for a few introductory comments.
Thank you so much. Before we begin today, I'd like to remind everyone that as part of today's call, we will make certain comments about AtriCure's future expectations, plans and prospects that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, expectations regarding the timing of FDA review, expectations regarding FDA's response and whether it will approve CONVERGE, the potential CONVERGE launch timing, the potential market opportunities for CONVERGE and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)